CliffBio
small molecule

POTASSIUM CHLORIDE

POTASSIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNexus Labs →See this company's full patent-cliff portfolio

Drug detail

Brand namePOTASSIUM CHLORIDE
Active ingredientPOTASSIUM CHLORIDE
Strength2MEQ/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 2023
Marketing statusRX

More from Nexus Labs

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

POTASSIUM CHLORIDE patent cliff — loss of exclusivity — | CliffBio